Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan J Molenaar

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Current Opinion in Oncology|December 6, 2013
Prevalence and clinical implications of chromothripsis in cancer genomesWigard P Kloosterman, Jan Koster, Jan J Molenaar
Cancers|September 10, 2021
The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial DevelopmentKarin P S Langenberg, Eleonora J Looze, Jan J Molenaar
Endocrine-Related Cancer|October 6, 2011
Neuroblastoma therapy: what is in the pipeline?Carla S Verissimo, Jan J Molenaar, Carlos P Fitzsimons, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2023
Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challengesElisa Zappa, Alice Vitali, Kathleen Anders, et al.
Genes, Chromosomes & Cancer|January 31, 2003
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastomaJan J Molenaar, Peter van Sluis, Kathy Boon, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expressionFieke Lamers, Linda Schild, Jan Koster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 9, 2023
Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In VitroRonja Pscheid, Esther Drent, Judith Wienke, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncologyJudith Wienke, Miranda P Dierselhuis, Godelieve A M Tytgat, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 2025
The immune landscape of pediatric (extra)cranial solid tumors: A systematic review and integration of immunohistochemistry and single-cell RNA sequencing dataFrancisca J Bergsma, Jan Koster, Bob Baalman, et al.
Cancer Research|April 17, 2008
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastomaJan J Molenaar, Marli E Ebus, Jan Koster, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Current Opinion in Oncology|December 6, 2013
Prevalence and clinical implications of chromothripsis in cancer genomesWigard P Kloosterman, Jan Koster, Jan J Molenaar
Cancers|September 10, 2021
The Landscape of Pediatric Precision Oncology: Program Design, Actionable Alterations, and Clinical Trial DevelopmentKarin P S Langenberg, Eleonora J Looze, Jan J Molenaar
Endocrine-Related Cancer|October 6, 2011
Neuroblastoma therapy: what is in the pipeline?Carla S Verissimo, Jan J Molenaar, Carlos P Fitzsimons, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2023
Adoptive cell therapy in paediatric extracranial solid tumours: current approaches and future challengesElisa Zappa, Alice Vitali, Kathleen Anders, et al.
Genes, Chromosomes & Cancer|January 31, 2003
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastomaJan J Molenaar, Peter van Sluis, Kathy Boon, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expressionFieke Lamers, Linda Schild, Jan Koster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 9, 2023
Three-Dimensional Modeling of Solid Tumors and Their Microenvironment to Evaluate T Cell Therapy Efficacy In VitroRonja Pscheid, Esther Drent, Judith Wienke, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncologyJudith Wienke, Miranda P Dierselhuis, Godelieve A M Tytgat, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 2025
The immune landscape of pediatric (extra)cranial solid tumors: A systematic review and integration of immunohistochemistry and single-cell RNA sequencing dataFrancisca J Bergsma, Jan Koster, Bob Baalman, et al.
Cancer Research|April 17, 2008
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastomaJan J Molenaar, Marli E Ebus, Jan Koster, et al.
Pageof 11